Artificial Intelligence and machine learning have seeped into almost every aspect of human lives, including healthcare, and life sciences. Perhaps the most beneficial implementation of AI in healthcare is the early-detection of life-endangering diseases such as cancer, heart diseases, and other neurological disorders. In healthcare, time is crucial. Early diagnostics lead to timely treatment; thereby saving lives. Combining machine learning with blood diagnostics to deliver faster and efficient point-of-care testing is what Tel Aviv-based Sight Diagnostics is striving to achieve, and it just raised $71 million (€60.2 million approx) in Series D funding.
Sight Diagnostics’ Series D
Sight Diagnostics is an Israeli medical device startup that uses machine vision and AI to offer point-of-care blood diagnostics, including Complete Blood Count (CBC), at the doctor’s office itself; with the test results made available within a few minutes.